Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
ViiV Healthcare Announces First Phase II HIV Prevention Study Results for Investigational Long-acting Injectable Cabotegravir 2016-02-25 01:34
ViiV Healthcare Announces Phase II Study Results for First Two Drug, Long-acting Injectable Regimen for HIV-1 Treatment 2016-02-24 04:03
1